Intelligence · Clinical Development
Pipeline search results
Programs matching “Novartis” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 341 pipeline programs matching "Novartis" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
LCZ696
Novartis Pharmaceuticals
Hypertension
2 trials -
LDE225 0.75%
Novartis Pharmaceuticals
Sporadic Superficial and Nodular Skin Basal Cell Carcinomas
1 trial -
LIK066
Novartis Pharmaceuticals
Obese Patients With Non-alcoholic Steatohepatitis (NASH)
1 trial -
LNA043
Novartis Pharmaceuticals
Osteoarthritis
1 trial -
MAS825, -
Novartis Pharmaceuticals
Still’s disease
1 trial -
Midostaurin
Novartis Pharmaceuticals
Acute Myeloid Leukemia
1 trial -
Nilotinib followed by treatment-free
Novartis Pharmaceuticals
Chronic Myelogenous Leukemia
1 trial -
Osilodrostat
Novartis Pharmaceuticals
Cushing's Syndrome
1 trial -
PHE885
Novartis Pharmaceuticals
Multiple Myeloma
1 trial -
PPY988A
Novartis Pharmaceuticals
Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in participants already treated with GT005 in the previous studies GT005-01 (FOCUS), GT005-02 (EXPLORE) and GT005-03 (HORIZON).
1 trial -
Panobinostat
Novartis Pharmaceuticals
Classical Hodgkin's Lymphoma
1 trial -
Patupilone
Novartis Pharmaceuticals
Hepatocellular Carcinoma
1 trial -
QBW251
Novartis Pharmaceuticals
Pulmonary Disease, Chronic Obstructive
1 trial -
Rapcabtagene autoleucel
Novartis Pharmaceuticals
ANCA Associated Vasculitis (AAV)
1 trial -
SODIUM CHLORIDE , DII235
Novartis Pharmaceuticals
Cardiovascular risk reduction in participants with elevated Lp(a)
1 trial -
Scemblix 40 mg film-coated tablets
Novartis Pharmaceuticals
CML-CP or CML-AP patients with T315I mutation
1 trial -
Seasonal flu vaccine
Novartis Pharmaceuticals
Seasonal Influenza
1 trial -
Serelaxin
Novartis Pharmaceuticals
Acute Heart Failure
1 trial -
TISAGENLECLEUCEL
Novartis Pharmaceuticals
High-risk B-cell acute lymphoblastic leukemia
1 trial -
TISAGENLECLEUCEL
Novartis Pharmaceuticals
Adult patients with refractory or relapsed follicular lymphoma
1 trial -
Vi-CRM197 vaccine
Novartis Pharmaceuticals
Typhoid Fever
1 trial -
alb-interferon alfa 2b
Novartis Pharmaceuticals
Chronic Hepatitis C
1 trial -
cyclosporine (reduced exposure) / everolimus
Novartis Pharmaceuticals
Kidney Transplantation
1 trial -
eltrombopag
Novartis Pharmaceuticals
Thrombocytopaenia
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.